Omada Health, Inc.

Compare

136 Followers

OMDA Stock Chart & Stats

$26.78

-$4.40(-19.47%)

At close: Jun 10 4:00 PM EDT

$26.78

-$4.40(-19.47%)

Day’s Range― - ―

52-Week Range$14.14 - $28.40

Previous Close$18.29

Volume2.54M

Average Volume (3M)428.83K

Market Cap

$1.49B

Enterprise Value$855.79M

Total Cash (Recent Filing)$223.15M

Total Debt (Recent Filing)$29.97M

Price to Earnings (P/E)―

Beta2.66

Next Earnings

Aug 07, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding57,574,920

10 Day Avg. Volume218,891

30 Day Avg. Volume428,833

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.57

Enterprise Value/Revenue7.36

Enterprise Value/Gross Profit11.87

Enterprise Value/Ebitda-86.39

Forecast

1Y Price Target

$27.43

Price Target Upside2.43% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering7

Bulls Say, Bears Say

Bulls Say

App Downloads And GrowthOmada app downloads increased 81% Y/Y in Q3, the second highest in history, pointing to upside to net new member additions and highlighting a widening of Omada's lead over competitors.

Financial PerformanceThe company’s first earnings report showed significant proof of performance, with gross margin expanding significantly and the majority of revenue upside contributing to EBITDA.

GLP-1 Care TrackRecent GLP-1 Care Track disclosure indicates 100k members on the program, 2x the level of members disclosed earlier in the year, suggesting potential for significant member growth.

Bears Say

Omada Health, Inc. News

Omada Health appoints Tsang as Chief Medical Officer

Omada Health (OMDA) announced the appointment of Thomas Tsang, MD, MPH as Chief Medical Officer. Dr. Tsang brings...

3d ago

OMDA

Omada Health price target raised to $28 from $24 at Barclays

Barclays raised the firm’s price target on Omada Health (OMDA) to $28 from $24 and keeps an Overweight...

8d ago

OMDA

Omada Health added to ‘Tactical Outperform’ list at Evercore ISI

Evercore ISI analyst Elizabeth Anderson added Omada Health (OMDA) to the firm’s “Tactical Outperform” list as the firm...

22d ago

OMDA

Omada Health launches “Meal Map” AI-powered nutrition tool

Omada Health (OMDA) launches Meal Map, a new nutrient-categorization tool that combines AI-powered instant feedback with human care...

29d ago

OMDA

Omada Health’s Surge in App Downloads and GLP-1 Care Track Expansion Justify Buy Rating

Morgan Stanley analyst Craig Hettenbach maintained a Buy rating on Omada Health, Inc. today and set a price...

17d ago

OMDA

Omada Health announces analysis on weight maintenance post GLP-1 discontinuation

Omada Health (OMDA) released results from a real-world analysis that showed 63% of Omada members maintained or continued...

2M ago

OMDA

Omada Health initiated with a Neutral at Baird

Baird last night initiated coverage of Omada Health (OMDA) with a Neutral rating and $24 price target The...

2M ago

OMDA

Omada Health initiated with a Neutral at Baird

Baird analyst Vikram Kesavabhotla initiated coverage of Omada Health (OMDA) with a Neutral rating and $24 price target...

2M ago

OMDA

Omada Health announce research on cost savings of virtual physical therapy

Omada Health (OMDA) released new data demonstrating that patients who used Omada’s virtual physical therapy program to address...

2M ago

OMDA

Five new option listings and one option delisting on August 22nd

New option listings for August 22nd include Tradr 2X Long LRCX Daily ETF (LRCU), Mill City Ventures III...

2M ago

VNM

ENZB

Omada Health price target raised to $28 from $27 at Canaccord

Canaccord raised the firm’s price target on Omada Health (OMDA) to $28 from $27 and keeps a Buy...

3M ago

OMDA

Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating

Omada Health, Inc., the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ryan MacDonald...

3M ago

OMDA

Omada Health Reports Strong Q2 2025 Growth

Omada Health, Inc. ( ($OMDA) ) has released its Q2 earnings. Here is a breakdown of the information...

3M ago

OMDA

Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook

Canaccord Genuity analyst Richard Close maintained a Buy rating on Omada Health, Inc. yesterday and set a price...

3M ago

OMDA

OMDA FAQ

What was Omada Health, Inc.’s price range in the past 12 months?

Omada Health, Inc. lowest stock price was $14.14 and its highest was $28.40 in the past 12 months.

What is Omada Health, Inc.’s market cap?

Omada Health, Inc.’s market cap is $1.49B.

When is Omada Health, Inc.’s upcoming earnings report date?

Omada Health, Inc.’s upcoming earnings report date is Aug 07, 2025 which is 84 days ago.

How were Omada Health, Inc.’s earnings last quarter?

Omada Health, Inc. released its earnings results on Aug 07, 2025. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.118 by -$0.122.

Is Omada Health, Inc. overvalued?

According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Omada Health, Inc. pay dividends?

Omada Health, Inc. does not currently pay dividends.

What is Omada Health, Inc.’s EPS estimate?

Omada Health, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Omada Health, Inc. have?

Omada Health, Inc. has 57,574,920 shares outstanding.

What happened to Omada Health, Inc.’s price movement after its last earnings report?

Omada Health, Inc. reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.118. Following the earnings report the stock price went down -2.261%.

Which hedge fund is a major shareholder of Omada Health, Inc.?

Currently, no hedge funds are holding shares in OMDA

Omada Health, Inc. Stock Smart Score

Neutral

Company Description

Omada Health, Inc.

Omada Health, Inc. is a digital health company that specializes in chronic disease management and prevention. The company focuses on providing evidence-based health programs designed to help individuals manage conditions such as diabetes, hypertension, and obesity. Utilizing a combination of personalized coaching, digital tools, and data analytics, Omada aims to improve health outcomes for its users while reducing healthcare costs for employers and health plans. Its core products include comprehensive digital health programs that support lifestyle changes through behavioral health interventions and remote monitoring.

Omada Health, Inc. (OMDA) Earnings & Revenues

Historic Earnings Reports

OMDA Company Deck

OMDA Earnings Call

Q2 2025

0:00 / 0:00

OMDA Stock 12 Month Forecast

Average Price Target

$27.43

▲(2.43% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"$16","20":"$20","24":"$24","28":"$28","32":"$32"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$31.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":27.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$27.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,20,24,28,32],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.42,23.080000000000002,23.740000000000002,24.400000000000002,25.060000000000002,25.720000000000002,26.380000000000003,27.04,27.700000000000003,28.36,29.020000000000003,29.68,30.34,{"y":31,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.42,22.805384615384618,23.19076923076923,23.576153846153847,23.961538461538463,24.346923076923076,24.732307692307693,25.11769230769231,25.503076923076925,25.888461538461538,26.273846153846154,26.659230769230767,27.044615384615383,{"y":27.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,22.42,22.54153846153846,22.663076923076925,22.784615384615385,22.90615384615385,23.02769230769231,23.14923076923077,23.270769230769233,23.392307692307693,23.513846153846153,23.635384615384616,23.756923076923076,23.87846153846154,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.6,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":22.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.25,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.77,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.42,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >